Fig. 1From: Update of statistical analysis plan for: Integration of smoking cessation into standard treatment for patients receiving opioid agonist therapy who are smoking tobacco: protocol for a randomised controlled trial (ATLAS4LAR)CONSORT Flow diagram. “1” indicates the following: persons who died between the date of randomization and the date of outcome evaluation (weeks 12–16) will not be included in the ITT/PP analyses but presented in the trial profile and assessed for potential severe adverse eventsableBack to article page